Market Cap N/A
Revenue (ttm) 22.77M
Net Income (ttm) -196.30M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 19,600
Avg Vol 12,054
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 89%
Beta N/A
Analysts Strong Sell
Price Target N/A

Company Profile

Celularity Inc., a regenerative and cellular medicines company, focuses on addressing aging-related and degenerative diseases. It develops off-the-shelf placental-derived allogeneic cell therapy product candidates, including mesenchymal-like adherent stromal cells for diabetic foot ulcer and Crohn's disease. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. Its therapeutic programs include PDA-001 for the treatment of autoimmune (Crohn's) and degene...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 768 2170
Address:
170 Park Avenue, Florham Park, United States
Latest News on CELUW
No data available.